| Literature DB >> 29793527 |
Ulla Klaiber1, Lisa M Stephan-Paulsen1, Thomas Bruckner2, Gisela Müller1, Silke Auer1, Ingrid Farrenkopf1, Christine Fink1, Colette Dörr-Harim1, Markus K Diener1, Markus W Büchler1, Phillip Knebel3.
Abstract
BACKGROUND: The prevention of postoperative complications is of prime importance after complex elective abdominal operations. Preoperative patient education may prevent postoperative complications and improve patients' wellbeing, but evidence for its efficacy is poor. The aims of the PEDUCAT trial were (a) to assess the impact of preoperative patient education on postoperative complications and patient-reported outcomes in patients scheduled for elective complex visceral surgery and (b) to evaluate the feasibility of cluster randomization in this setting.Entities:
Keywords: Cluster randomization; Patient education; Postoperative complication; Preoperative education; Prevention; Visceral surgery
Mesh:
Year: 2018 PMID: 29793527 PMCID: PMC5968532 DOI: 10.1186/s13063-018-2676-6
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Fig. 1Flow diagram. PP, per protocol; ITT, intention to treat
Baseline characteristics of the intention-to-treat analysis population
| Patient education + information brochure ( | Information brochure only ( | |
|---|---|---|
| Sex | ||
| Male | 74 (53.6%) | 56 (52.8%) |
| Female | 64 (46.4%) | 50 (47.2%) |
| Age (years) | 57.0 (14.0) | 56.8 (13.4) |
| Body mass index (kg/m2) | 25.1 (4.2) | 25.7 (5.2) |
| ASA classification | ||
| I (normal healthy patient) | 7 (5.1%) | 4 (3.8%) |
| II (mild systemic disease) | 72 (52.2%) | 60 (56.6%) |
| III (severe systemic disease) | 58 (42.0%) | 41 (38.7%) |
| IV (constant threat to life) | 1 (0.7%) | 1 (0.9%) |
| Target organ for operation | ||
| Esophagus | 3 (2.2%) | 4 (3.8%) |
| Stomach | 9 (6.5%) | 5 (4.7%) |
| Small intestine | 5 (3.6%) | 6 (5.7%) |
| Colon | 19 (13.8%) | 14 (13.2%) |
| Rectum | 9 (6.5%) | 8 (7.5%) |
| Pancreas | 59 (42.8%) | 39 (36.8%) |
| Liver | 12 (8.7%) | 13 (12.3%) |
| Kidney | 9 (6.5%) | 6 (5.7%) |
| Other | 13 (9.4%) | 11 (10.4%) |
| Comorbidities | ||
| Chronic cardiovascular disease | 41 (29.7%) | 36 (34.0%) |
| Chronic pulmonary disease | 15 (10.9%) | 12 (11.3%) |
| History of deep vein thrombosis | 10 (7.2%) | 13 (12.3%) |
| History of pulmonary embolism | 1 (0.7%) | 5 (4.7%) |
| Diabetes mellitus | 21 (15.2%) | 9 (8.5%) |
| Other significant disease | 66 (47.8%) | 48 (45.3%) |
| Previous laparotomy (incision > 10 cm) | 59 (42.8%) | 39 (36.8%) |
| Duration of operation (min) | 211.9 (116.9) | 216.3 (110.7) |
Data are means (with standard deviations) or numbers of patients (with percentages)
ASA American Society of Anesthesiologists
Postoperative morbidity and mortality within 30 days and length of hospital stay
| Patient education + information brochure ( | Information brochure only ( | ||
|---|---|---|---|
| Postoperative morbidity | |||
| Pneumonia | 0.807* | ||
| | 121 | 96 | |
| | 9 (7.4%) | 8 (8.3%) | |
| Deep vein thrombosis | Not applicable | ||
| | 120 | 96 | |
| | 0 (0.0%) | 0 (0.0%) | |
| Pulmonary embolism | 0.707* | ||
| | 122 | 96 | |
| | 2 (1.6%) | 1 (1.0%) | |
| Burst abdomen | 0.165* | ||
| | 120 | 96 | |
| | 5 (4.2%) | 1 (1.0%) | |
| In-hospital fall | |||
| | 120 | 96 | |
| | 0 (0.0%) | 4 (4.2%) | |
| Composite endpointa | 0.704* | ||
| | 120 | 96 | |
| | 13 (10.8%) | 12 (12.5%) | |
| Mortality | 0.790* | ||
| | 138 | 106 | |
| | 2 (1.4%) | 2 (1.9%) | |
| Length of hospital stay (days) | 0.285† | ||
| | 138 | 106 | |
| | 14.2 (12.0) | 16.1 (15.0) | |
Significant results (p value < 0.05) are in bold
Data are means (with standard deviations) or numbers of patients (with percentages)
aPatients with at least one complication
*χ2 test
†t test
N Number of patients available for the outcome analyzed
n Number of events
Quality of life
| Patient education + information brochure ( | Information brochure only ( | ||
|---|---|---|---|
| At baseline | |||
| Short Form (SF)-12 physical health score | 0.298† | ||
| | 116 | 89 | |
| Mean (±SD) | 44.0 (±10.9) | 42.4 (±11.3) | |
| SF-12 mental health score | 0.514† | ||
| | 116 | 89 | |
| Mean (±SD) | 43.4 (±11.6) | 44.5 (±12.0) | |
| At 30 days after operation | |||
| SF-12 physical health score | 0.179† | ||
| | 82 | 68 | |
| Mean (±SD) | 32.2 (±7.3) | 33.9 (±7.5) | |
| SF-12 mental health score | 0.848† | ||
| | 82 | 68 | |
| Mean (±SD) | 43.4 (±11.7) | 43.8 (±12.4) | |
†t test
Postoperative pain
| Patient education + information brochure ( | Information brochure only ( | ||
|---|---|---|---|
| At baseline | |||
| Pain at its worst in the past 24 h. | 0.859* | ||
| | 136 | 105 | |
| Mean (±SD) | 1.9 (±2.7) | 1.8 (±2.5) | |
| Pain on average in the past 24 h. | 0.958* | ||
| | 136 | 104 | |
| Mean (±SD) | 1.4 (±2.0) | 1.4 (±2.0) | |
| Pain right now | 0.820* | ||
| | 136 | 105 | |
| Mean (±SD) | 1.1 (±1.8) | 1.1 (±1.8) | |
| In the past 24 h, pain has interfered with ... | |||
| ... mood | 0.404* | ||
| | 136 | 105 | |
| Mean (±SD) | 1.7 (±2.5) | 1.6 (±2.5) | |
| ... walking ability | 0.505* | ||
| | 135 | 105 | |
| Mean (±SD) | 1.0 (±1.9) | 0.8 (±1.6) | |
| ... relation with other people | 0.749* | ||
| | 136 | 105 | |
| Mean (±SD) | 0.9 (±1.8) | 1.0 (±2.0) | |
| ... sleep | 0.776* | ||
| | 135 | 105 | |
| Mean (±SD) | 2.1 (±2.9) | 2.1 (±3.0) | |
| ... concentration | 0.929* | ||
| | 136 | 104 | |
| Mean (±SD) | 1.5 (±2.2) | 1.6 (±2.3) | |
| At 2 days after operation | |||
| Pain at its worst in the past 24 h | 0.515* | ||
| | 131 | 95 | |
| Mean (±SD) | 5.7 (±2.8) | 5.9 (±2.8) | |
| Pain on average in the past 24 h | 0.559* | ||
| | 131 | 95 | |
| Mean (±SD) | 3.6 (±2.2) | 3.8 (±2.1) | |
| Pain right now. | 0.759* | ||
| N | 131 | 95 | |
| Mean (±SD) | 2.5 (±2.3) | 2.5 (±2.5) | |
| In the past 24 h, pain has interfered with ... | |||
| ... mood | 0.463* | ||
| | 131 | 93 | |
| Mean (±SD) | 3.7 (±3.4) | 4.1 (±3.4) | |
| ... walking ability | 0.293* | ||
| | 131 | 93 | |
| Mean (±SD) | 5.0 (±3.5) | 5.4 (±3.4) | |
| ... relation with other people | 0.939* | ||
| | 127 | 92 | |
| Mean (±SD) | 2.4 (±3.0) | 2.4 (±3.0) | |
| ... sleep | 0.423* | ||
| | 131 | 94 | |
| Mean (±SD) | 3.4 (±3.3) | 3.9 (±3.5) | |
| ... concentration | 0.752* | ||
| | 131 | 93 | |
| Mean (±SD) | 3.4 (±3.2) | 3.5 (±3.4) | |
| At 7 days after operation | |||
| Pain at its worst in the past 24 h | 0.835* | ||
| | 121 | 88 | |
| Mean (±SD) | 4.1 (±2.9) | 4.1 (±2.7) | |
| Pain on average in the past 24 h | 0.487* | ||
| | 121 | 88 | |
| Mean (±SD) | 2.8 (±2.0) | 2.6 (±1.9) | |
| Pain right now | |||
| | 121 | 87 | |
| Mean (±SD) | 2.3 (±1.9) | 1.8 (±2.0) | |
| In the past 24 h, pain has interfered with ... | |||
| ... mood | 0.705* | ||
| | 120 | 86 | |
| Mean (±SD) | 3.3 (±2.9) | 3.2 (±3.1) | |
| ...walking ability | 0.433* | ||
| | 121 | 87 | |
| Mean (±SD) | 3.0 (±2.5) | 3.4 (±3.0) | |
| ... relation with other people | 0.202* | ||
| | 119 | 87 | |
| Mean (±SD) | 2.1 (±2.4) | 1.7 (±2.4) | |
| ... sleep | 0.747* | ||
| | 119 | 88 | |
| Mean (±SD) | 3.7 (±2.8) | 3.6 (±3.0) | |
| ... concentration | 0.894* | ||
| | 120 | 88 | |
| Mean (±SD) | 2.8 (±2.7) | 2.9 (±3.1) | |
Significant results (p value < 0.05) are in bold
*U test
Perioperative anxiety and depression
| Patient education + information brochure ( | Information brochure only ( | ||
|---|---|---|---|
| At baseline | |||
| Hospital anxiety scale | 0.527† | ||
| | 135 | 103 | |
| Mean (±SD) | 10.7 (±1.7) | 10.8 (±1.9) | |
| Hospital depression scale | 0.297† | ||
| | 135 | 104 | |
| Mean (±SD) | 9.5 (±1.9) | 9.7 (±1.6) | |
| At 7 days after operation | |||
| Hospital anxiety scale | 0.389† | ||
| | 118 | 88 | |
| Mean (±SD) | 11.1 (±1.7) | 11.3 (±2.0) | |
| Hospital depression scale | 0.202† | ||
| | 119 | 88 | |
| Mean (±SD) | 9.7 (±1.8) | 10.0 (±2.0) | |
| At 30 days after operation | |||
| Hospital anxiety scale | 0.479† | ||
| | 100 | 78 | |
| Mean (±SD) | 10.9 (±1.5) | 11.0 (±1.6) | |
| Hospital depression scale |
| ||
| | 100 | 78 | |
| Mean (±SD) | 9.6 (±1.5) | 10.0 (±1.5) | |
Significant results (p value < 0.05) are in bold
†t test
Patient satisfaction
| Patient education + information brochure ( | Information brochure only ( | ||
|---|---|---|---|
| “I have been informed about the correct behavior after the operation sufficiently” | 0.473* | ||
| | 117 | 88 | |
| Mean (±SD) | 1.8 (±1.0) | 1.8 (±1.0) | |
| “I feel insecure and I am afraid of doing something wrong” | 0.911* | ||
| | 118 | 87 | |
| Mean (±SD) | 3.1 (±1.4) | 3.1 (±1.4) | |
| “Before the operation, I had enough possibilities to address my worries” | 0.683* | ||
| | 118 | 87 | |
| Mean (±SD) | 1.9 (±1.1) | 1.9 (±1.1) | |
| “I felt sufficiently prepared for the operation” | 0.567* | ||
| | 115 | 88 | |
| Mean (±SD) | 1.7 (±1.0) | 1.6 (±1.0) | |
| “The preoperative education has influenced postoperative recovery in a positive way” | Not applicable | ||
| | 86 | Not available | |
| Mean (±SD) | 1.8 (±0.8) | ||
| “The preoperative education has encouraged me to take part in postoperative recovery actively” | Not applicable | ||
| | 86 | Not available | |
| Mean (±SD) | 1.7 (±0.9) | ||
| “The preoperative patient education was important for me” | Not applicable | ||
| | 86 | Not available | |
| Mean (±SD) | 1.7 (±0.9) |
Unvalidated questionnaire: 1 = completely agree, 5 = not correct at all
*U test
Fig. 2Postoperative course of quality of life. Blue, intervention group; green, control group; POD, postoperative day
Fig. 3Postoperative course of pain. Blue, intervention group; green, control group; POD, postoperative day
Fig. 4Postoperative course of anxiety and depression. Blue, intervention group; green, control group; POD, postoperative day
Serious adverse events
| Patient education + information brochure ( | Information brochure only ( | ||
|---|---|---|---|
| Occurrence of SAE | 13 (9.4%) | 10 (9.4%) | 0.997* |
| Severity | 0.772* | ||
| Grade IV* | 11 (84.6%) | 8 (80.0%) | |
| Grade V* | 2 (15.4%) | 2 (20.0%) | |
| Causality | Not applicable | ||
| Unrelated | 13 (100%) | 10 (100%) | |
| Possibly related | 0 (0%) | 0 (0%) | |
| Definitely related | 0 (0%) | 0 (0%) | |
| Outcome | 0.361* | ||
| Recovered completely | 3 (23.1%) | 3 (30.0%) | |
| Recovered with sequelae | 4 (30.8%) | 2 (20.0%) | |
| Death | 2 (15.4%) | 2 (20.0%) | |
| Unknown | 1 (7.7%) | 3 (30.0%) | |
| Ongoing | 3 (23.1%) | 0 (0%) |
Data are numbers of patients (with percentages)
SAE serious adverse events
*χ2 test